immuno-oncology program (Bioleaders)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameimmuno-oncology program (Bioleaders)

Drug Alias NameBLS-MX024MX024BLS-M102BLS-M101

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBL Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBL Corp

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A